Literature DB >> 27404679

Amelioration of right ventricular function after hybrid therapy with riociguat and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.

Toshimitsu Tsugu1, Mitsushige Murata2, Takashi Kawakami1, Masaharu Kataoka1, Yuji Nagatomo3, Hikaru Tsuruta1, Yuji Itabashi1, Yuichiro Maekawa1, Keiichi Fukuda1.   

Abstract

Entities:  

Keywords:  Balloon pulmonary angioplasty; Chronic thromboembolic pulmonary hypertension; Right ventricular dyssynchrony; Soluble guanylate cyclase stimulator

Mesh：

Substances：

Year:  2016        PMID： 27404679     DOI： 10.1016/j.ijcard.2016.06.331

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  3 in total

1.  Meta-analysis of use of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension.

Authors:  Muhammad Shahzeb Khan; Emaan Amin; Muhammad Mustafa Memon; Naser Yamani; Tariq Jamal Siddiqi; Safi U Khan; Mohammad Hassan Murad; Farouk Mookadam; Vincent M Figueredo; Rami Doukky; Raymond L Benza; Richard A Krasuski
Journal:  Int J Cardiol       Date:  2019-02-23       Impact factor: 4.164

Review 2.  A Brief Overview of Nitric Oxide and Reactive Oxygen Species Signaling in Hypoxia-Induced Pulmonary Hypertension.

Authors:  Ariel Jaitovich; David Jourd'heuil
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

3.  Balloon pulmonary angioplasty combined with riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (PRACTICE study): study protocol for a randomized controlled trial.

Authors:  Qin-Hua Zhao; Su-Gang Gong; Jing He; Ping Yuan; Wen-Hui Wu; Ci-Jun Luo; Rong Jiang; Rui Zhang; Hong-Ling Qiu; Hui-Ting Li; Yuan Li; Jin-Ming Liu; Lan Wang
Journal:  Trials       Date:  2021-12-27       Impact factor: 2.279
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.